ITMCTR2000003816尚未招募1 期
The complement pathway and related inflammatory factor markers in the treatment of idiopathic membranous nephropathy
onghua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine0 个研究点开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Diagnostic test
入排标准
- 年龄范围
- 18 至 80（—）
- 性别
- All
入选标准
- •1. The clinical and pathological diagnosis was membranous nephropathy;
- •2. Aged 18-90 years old;
- •3. the patient was hospitalized within 24 hours after the onset of the disease;
- •4. there was no history of heart, liver dysfunction, severe anemia, leucopenia and thrombocytopenia.
排除标准
- •1. acute and chronic kidney diseases other than membranous nephropathy;
- •2. long-term immobilization;
- •3. recent surgery and blood transfusion;
- •4. incomplete clinical data;
- •5. heart and liver dysfunction;
- •6. severe anemia, leukopenia and thrombocytopenia;
- •7. patients with active gastric and duodenal ulcer;
- •8. severe arrhythmia;
- •9. children, child-bearing age with pregnancy requirements, pregnant women and lactation woman.
研究者
相似试验
进行中（未招募）
1 期
A Phase I Clinical Study of VSA012 in Healthy VolunteersHealthy VolunteersNCT06766929Bisirna Therapeutics (Suzhou) Co., Ltd.40
招募中
不适用
Investigation of complement activation and autoantibody formation in lysosomal storage diseases: Fabry disease and Gaucher's diseaseGaucher's diseaseFabry diseaseE75.2Other sphingolipidosisDRKS00022211eleva GmbH150
已完成
2 期
Complement Component 3c and Tumor Necrosis Factor-α in Patients With Human Papillomavirus-Induced Cutaneous WartsWartsNCT04399577Zagazig University39
尚未招募
不适用
Interferon, complement and immune cell imbalances in pregnant women with systemic autoimmune diseasesNL-OMON51715Reumatologie en Klinische Immunologie59
尚未招募
不适用
Identification of complement inhibitors and complement regulatory proteins in ABO-incompatible compare with HLA-incompatible kidney transplantatioABOi kidney transplantationHLAi kidney transplantationAccommodationABO incompatibility or ABO incompatible kidney transplantationComplement regulatory proteinsComplement inhibitorsHLA incompatibility or HLA incompatible kidney transplantationKidney transplantationTCTR20210904002/A30